Erschienen in:
08.01.2016 | Health Economy
Double versus single reading of mammograms in a breast cancer screening programme: a cost-consequence analysis
verfasst von:
Margarita C. Posso, Teresa Puig, Ma Jesus Quintana, Judit Solà-Roca, Xavier Bonfill
Erschienen in:
European Radiology
|
Ausgabe 9/2016
Einloggen, um Zugang zu erhalten
Abstract
Objectives
To assess the costs and health-related outcomes of double versus single reading of digital mammograms in a breast cancer screening programme.
Methods
Based on data from 57,157 digital screening mammograms from women aged 50–69 years, we compared costs, false-positive results, positive predictive value and cancer detection rate using four reading strategies: double reading with and without consensus and arbitration, and single reading with first reader only and second reader only. Four highly trained radiologists read the mammograms.
Results
Double reading with consensus and arbitration was 15 % (Euro 334,341) more expensive than single reading with first reader only. False-positive results were more frequent at double reading with consensus and arbitration than at single reading with first reader only (4.5 % and 4.2 %, respectively; p < 0.001). The positive predictive value (9.3 % and 9.1 %; p = 0.812) and cancer detection rate were similar for both reading strategies (4.6 and 4.2 per 1000 screens; p = 0.283).
Conclusions
Our results suggest that changing to single reading of mammograms could produce savings in breast cancer screening. Single reading could reduce the frequency of false-positive results without changing the cancer detection rate. These results are not conclusive and cannot be generalized to other contexts with less trained radiologists.
Key Points
• Double reading of digital mammograms is more expensive than single reading.
• Compared to single reading, double reading yields a higher proportion of false-positive results.
• The cancer detection rate was similar for double and single readings.
• Single reading may be a cost-effective strategy in breast cancer screening programmes.